Partnering opportunity

German university research institute is looking for developer of anti-inflammation compounds targeting connexin hemichannels to test their cell and ex vivo tissue model

Summary

A German research institute wants to use its cell and ex vivo tissues as platform to test connexin (Cx) hemichannel inhibitors as drugs for the treatment of chronic inflammation-related diseases. Cxs form cell-to-cell channels between adjacent cells as well as hemichannels in single cells. Cx hemichannels are upregulated during inflammation and participate to further release of injury signals. The institute is looking for laboratories and companies to develop and test potential inhibitors.

Technical Specification or Expertise Sought

Potential partners are chemical laboratories or pharmacological companies that have expertise in drug compound development, and if possible especially in connexin hemichannel inhibitors. The partner should develop those inhibitors/drugs in cooperation with the research institute. These compounds then can be tested by the research institute with the above described cell and ex vivo model system.

Partner sought

Based on the above described system the research institute is looking for and would like to cooperate with chemistry laboratories and pharmacological companies to develop and test inhibitors to specifically inhibit connexin hemichannels. The inhibitors can have potential for further development in drugs for treatment of inflammation related impairments.

Description

The German research institute has established a basis platform of cells and ex vivo tissues to analyse the upregulation of specific connexin hemichannels induced by the inflammation-initiators and inflammation-mediators. With this system it is possible to analyse the upregulation of connexin hemichannels in cells of different tissues. This platform can be used to develop connexin hemichannel inhibitors as drugs for treatment of chronic inflammation-related diseases such as morbus Crohn or colitis in the intestine as well as cystic fibrosis (CFTR), idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD) and asthma in the airway, various neurodegenerative diseases like amyotrophic lateral sclerosis (ALS), Alzheimer or multiple sclerosis and other impairments like age-related muscle degeneration. The research institute has a long expertise in connexin physiology in various tissues such as the vascular system. Moreover the research institute has recently implemented a culture of epithelial cells on porous membranes in transwell systems. The culture allowed the cell to form a good barrier and to consider the polarized expression of the receptors and the resulting effect on the connexin channels. Moreover the system should also be used to introduce other cells in a co-culture system allowing the simulation of the in vivo situation. Co-cultures and ex vivo tissue models can be used to evaluate the role of identified mediators and connexins in the inflammation related impairments. Based on the current results and analysed cell systems, the involvement of Cx hemichannels should be characterized in the cellular response to bacterial toxins and markers, the so called inflammation initiators, as well as the inflammation mediators, such as cytokines or metabolites like nicotinamide adenine dinucleotide, nucleotides and oligonucleotides. The research institute is looking for chemical laboratories and pharmacological companies, which provide connexin hemichannel inhibitors to be tested with the developed cell and ex vivo model system. Possible types of partnership include but are not limited to a joint venture agreement, a research cooperation agreement or a technical cooperation agreement.

Advantages and innovations

Not available

Development stage

Not available

Intellectual Property Rights (IPR)

Not available


Register your interest

How it works

  • Tell us about yourself
  • We’ll discuss with you
  • We put the right partners in touch

EEN help you find the right partner, rather than you going it alone.

Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.

These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.

Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.

?What value does EEN add?
This is your pitch: remember to include your unique selling points (USP) and why someone would want to do business with you
Tell us why you are a good fit for this opportunity, and why you think you're the right people for this partnership
If there's anything additional, or commercially sensitive you'd like to know about this opportunity, please let us know

When you entered your email address above, we emailed you a code to verify you're human and have access to that account.

?What's this?

What next?

To finish up, we just need some extra details about you and your company